scPharmaceuticals Inc. (SCPH) Tops Q2 EPS by 1c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q2 EPS of ($0.36), $0.01 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $1.64 million versus the consensus estimate of $1.45 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• BofA expects Apple to top analyst expectations on July 30
• Piper Sandler on Globe Life (GL): 'A Stock to Watch Into Earnings This Week'
• HSBC sees "some proper warnings signs emerging" in risk assets